Along with IPV therapy’s clinical results in treating patients with respiratory complications, it has a demonstrated history of being safe and well-tolerated across diverse patient populations, care settings, and delivery interfaces.

We may not typically consider blood draws and heel sticks to be a large driver of patients losing blood, but the issue carries greater significance with neonatal patients, who don’t have much blood to give in the first place.

There is a long list of decisions to make when adopting new technology in a hospital unit, and transcutaneous monitoring is no exception. Some of the most overlooked decisions in our experience are those around mounting and storing the devices both during monitoring, while not in use, as well as for performing maintenance.

This animation offers a simple explanation for how transcutaneous monitoring works in the NICU to support balanced care for these fragile patients.